ISCO.OB Insider Trading Activity and SEC Form 4 Filings
ISCO.OB insider trading summary
No open-market insider purchases or sales of International Stem Cell CORP (ISCO.OB) have been reported on SEC Form 4 in the past 12 months.
Latest ISCO.OB insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 18, 2019 | Paul V Maier | Director | Sell | $2K (1,350 @ $1.25) |
| Jan 21, 2019 | Andrey Semechkin | Chief Executive Officer | Buy | $1.0M (599,222 @ $1.75) |
| Dec 4, 2018 | Sophia Garnette | VP, Legal Affairs & Operations | Sell | $16K (10,636 @ $1.54) |
| Dec 3, 2018 | Russell Kern | EVP and CSO | Sell | $3K (1,800 @ $1.67) |
| Oct 2, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $2K (1,494 @ $1.58) |
| Aug 21, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $8K (4,900 @ $1.58) |
| Aug 20, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $15K (9,304 @ $1.58) |
| Jul 13, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $2K (1,100 @ $1.58) |
| Jul 10, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $4K (2,833 @ $1.58) |
| Jun 26, 2018 | Sophia Garnette | VP, Legal Affairs & Operation | Sell | $318 (200 @ $1.59) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.